These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37498410)

  • 1. Measuring symptoms and toxicities: a 35-year experience.
    Loprinzi CL; Novotny P; Ruddy KJ; Jatoi A; Le-Rademacher J; Ehlers SL; Cathcart-Rake E; Lee M
    Support Care Cancer; 2023 Jul; 31(8):495. PubMed ID: 37498410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment.
    Reilly CM; Bruner DW; Mitchell SA; Minasian LM; Basch E; Dueck AC; Cella D; Reeve BB
    Support Care Cancer; 2013 Jun; 21(6):1525-50. PubMed ID: 23314601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Educational interventions for the management of cancer-related fatigue in adults.
    Bennett S; Pigott A; Beller EM; Haines T; Meredith P; Delaney C
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008144. PubMed ID: 27883365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Quality Brief of an Oncological Multisite Massage and Acupuncture Therapy Program to Improve Cancer-Related Outcomes.
    Fink J; Burns J; Perez Moreno AC; Kram JJF; Armstrong M; Chopp S; Maul SJ; Conway N
    J Altern Complement Med; 2020 Sep; 26(9):820-824. PubMed ID: 32924553
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptom burden: multiple symptoms and their impact as patient-reported outcomes.
    Cleeland CS
    J Natl Cancer Inst Monogr; 2007; (37):16-21. PubMed ID: 17951226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments.
    Godil SS; Parker SL; Zuckerman SL; Mendenhall SK; McGirt MJ
    Spine J; 2015 Jun; 15(6):1203-9. PubMed ID: 24076442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measuring disability of patients with low-back pain--validation of a German version of the Roland & Morris disability questionnaire].
    Exner V; Keel P
    Schmerz; 2000 Dec; 14(6):392-400. PubMed ID: 12800012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.
    Basch E; Wood WA; Schrag D; Sima CS; Shaw M; Rogak LJ; Kris MG; Shouery M; Bennett A; Atkinson T; Pietanza MC
    Clin Trials; 2016 Jun; 13(3):331-7. PubMed ID: 26542025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
    King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML;
    Qual Life Res; 2018 Jan; 27(1):59-74. PubMed ID: 29248998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
    Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
    Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.